# Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance

> **NCT04783207** · NA · COMPLETED · sponsor: **Amazentis SA** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Mitopure
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04783207
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2022-05-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04783207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04783207, "Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04783207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
